{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Co-infection", "Drug-induced hepatotoxicity", "HIV", "Pharmacogenetics", "Tuberculosis"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "39085767", "DateCompleted": {"Year": "2024", "Month": "08", "Day": "01"}, "DateRevised": {"Year": "2024", "Month": "08", "Day": "03"}, "Article": {"Language": ["eng"], "ELocationID": ["759", "10.1186/s12879-024-09638-w"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "31"}], "Journal": {"ISSN": "1471-2334", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2024", "Month": "Jul", "Day": "31"}}, "Title": "BMC infectious diseases", "ISOAbbreviation": "BMC Infect Dis"}, "ArticleTitle": "Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection.", "Pagination": {"StartPage": "759", "MedlinePgn": "759"}, "Abstract": {"AbstractText": ["Human immunodeficiency virus (HIV) and tuberculosis (TB) are major contributors to morbidity and mortality in sub-Saharan Africa including Cameroon. Pharmacogenetic variants could serve as predictors of drug-induced hepatotoxicity (DIH), in patients with TB co-infected with HIV. We evaluated the occurrence of DIH and pharmacogenetic variants in Cameroonian patients.", "Treatment-na\u00efve patients with HIV, TB or TB/HIV co-infection were recruited at three hospitals in Cameroon, between September 2018 and November 2019. Appropriate treatment was initiated, and patients followed up for 12 weeks to assess DIH. Pharmacogenetic variants were assessed by allele discrimination TaqMan SNP assays.", "Of the 141 treatment na\u00efve patients, the overall incidence of DIH was 38% (53/141). The highest incidence of DIH, 52% (32/61), was observed among HIV patients. Of 32 pharmacogenetic variants, the slow acetylation variants NAT2*5 was associated with a decreased risk of DIH (OR: 0.4; 95%CI: 0.17-0.96; p\u2009=\u20090.038), while NAT2*6 was found to be associated with an increased risk of DIH (OR: 4.2; 95%CI: 1.1-15.2; p\u2009=\u20090.017) among patients treated for TB. Up to 15 SNPs differed in \u2265\u20095% of allele frequencies among African populations, while 25 SNPs differed in \u2265\u20095% of the allele frequencies among non-African populations, respectively.", "DIH is an important clinical problem in African patients with TB and HIV. The NAT2*5 and NAT2*6 variants were found to be associated with DIH in the Cameroonian population. Prior screening for the slow acetylation variants NAT2*5 and NAT2*6 may prevent DIH in TB and HIV-coinfected patients."], "CopyrightInformation": "\u00a9 2024. The Author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Medicine, University of T\u00fcbingen, Wilhelmstrasse 27, 72074, T\u00fcbingen, Germany."}, {"Identifier": [], "Affiliation": "Faculty of Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Cho", "ForeName": "Frederick Nchang", "Initials": "FN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Sciences, University of Buea, Buea, Cameroon."}], "LastName": "Achidi", "ForeName": "Eric A", "Initials": "EA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Sciences, University of Buea, Buea, Cameroon."}, {"Identifier": [], "Affiliation": "Institute of Medical Research and Medicinal Plants Studies, Yaound\u00e9, Cameroon."}], "LastName": "Enoh", "ForeName": "Jude Eteneneng", "Initials": "JE"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Medicine, University of T\u00fcbingen, Wilhelmstrasse 27, 72074, T\u00fcbingen, Germany."}], "LastName": "Pallerla", "ForeName": "Srinivas Reddy", "Initials": "SR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Medicine, University of T\u00fcbingen, Wilhelmstrasse 27, 72074, T\u00fcbingen, Germany."}, {"Identifier": [], "Affiliation": "Vietnamese-German Centre for Medical Research, VG-CARE, Hanoi, Vietnam."}], "LastName": "Linh", "ForeName": "Le Thi Kieu", "Initials": "LTK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Medicine, University of T\u00fcbingen, Wilhelmstrasse 27, 72074, T\u00fcbingen, Germany."}, {"Identifier": [], "Affiliation": "Vietnamese-German Centre for Medical Research, VG-CARE, Hanoi, Vietnam."}], "LastName": "Tong", "ForeName": "Hoang Van", "Initials": "HV"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Research on Filariasis and other Tropical Diseases, Yaound\u00e9, Cameroon."}, {"Identifier": [], "Affiliation": "Faculty of Medicine and Biomedical Sciences, University of Yaound\u00e9 I, Yaound\u00e9, Cameroon."}], "LastName": "Kamgno", "ForeName": "Joseph", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Sciences, University of Yaound\u00e9 1, Yaound\u00e9, Cameroon."}], "LastName": "Penlap", "ForeName": "V\u00e9ronique Beng", "Initials": "VB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Medicine, University of T\u00fcbingen, Wilhelmstrasse 27, 72074, T\u00fcbingen, Germany."}, {"Identifier": [], "Affiliation": "Centre de Recherches Medicales de Lambarene (CERMEL), Lambarene, Gabon."}], "LastName": "Adegnika", "ForeName": "Ayola Akim", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre Interdisciplinaire de Recherches M\u00e9dicales de Franceville (CIRMF), Franceville, Gabon."}, {"Identifier": [], "Affiliation": "Department of Parasitology-Mycology and Tropical Medicine, Faculty of Medicine, Universit\u00e9 des Sciences de la Sant\u00e9 (USS), Libreville, Gabon."}], "LastName": "Lekana-Douki", "ForeName": "Jean-Bernard", "Initials": "JB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Parasitology-Mycology and Tropical Medicine, Faculty of Medicine, Universit\u00e9 des Sciences de la Sant\u00e9 (USS), Libreville, Gabon."}], "LastName": "Bouyou-Akotet", "ForeName": "Marielle Karine", "Initials": "MK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Clinical Pharmacology and pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of Congo."}], "LastName": "Kahunu", "ForeName": "Gauthier Mesia", "Initials": "GM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Clinical Pharmacology and pharmacovigilance, University of Kinshasa, Kinshasa, Democratic Republic of Congo."}], "LastName": "Lutete", "ForeName": "Gaston Tona", "Initials": "GT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Life Sciences, University of Lincoln, Lincoln, UK."}, {"Identifier": [], "Affiliation": "HerpeZ, University Teaching Hospital, Lusaka, Zambia."}], "LastName": "Bates", "ForeName": "Mathew", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "HerpeZ, University Teaching Hospital, Lusaka, Zambia."}], "LastName": "Tembo", "ForeName": "John", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Clinical Microbiology, University College London, London, UK."}], "LastName": "Elton", "ForeName": "Linzy", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Clinical Microbiology, University College London, London, UK."}], "LastName": "McHugh", "ForeName": "Timothy D", "Initials": "TD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Medicine, University of T\u00fcbingen, Wilhelmstrasse 27, 72074, T\u00fcbingen, Germany."}, {"Identifier": [], "Affiliation": "Centre de Recherches Medicales de Lambarene (CERMEL), Lambarene, Gabon."}, {"Identifier": [], "Affiliation": "Center for Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands."}], "LastName": "Grobusch", "ForeName": "Martin P", "Initials": "MP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Clinical Microbiology, University College London, London, UK."}, {"Identifier": [], "Affiliation": "National Institute for Health and Care Research Biomedical Research Centre, University College London, London, UK."}], "LastName": "Zumla", "ForeName": "Alimuddin", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Medicine, University of T\u00fcbingen, Wilhelmstrasse 27, 72074, T\u00fcbingen, Germany."}, {"Identifier": [], "Affiliation": "Fondation Congolaise pour la Recherche M\u00e9dicale (FCRM), Brazzaville, Republic of Congo."}], "LastName": "Ntoumi", "ForeName": "Francine", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Tropical Medicine, University of T\u00fcbingen, Wilhelmstrasse 27, 72074, T\u00fcbingen, Germany. t.velavan@uni-tuebingen.de."}, {"Identifier": [], "Affiliation": "Vietnamese-German Centre for Medical Research, VG-CARE, Hanoi, Vietnam. t.velavan@uni-tuebingen.de."}, {"Identifier": [], "Affiliation": "Faculty of Medicine, Duy Tan University, Da Nang, Vietnam. t.velavan@uni-tuebingen.de."}], "LastName": "Velavan", "ForeName": "Thirumalaisamy P", "Initials": "TP"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Infect Dis", "NlmUniqueID": "100968551", "ISSNLinking": "1471-2334"}, "ChemicalList": [{"RegistryNumber": "EC 2.3.1.5", "NameOfSubstance": "Arylamine N-Acetyltransferase"}, {"RegistryNumber": "EC 2.3.1.5", "NameOfSubstance": "NAT2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Antitubercular Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics"], "DescriptorName": "Arylamine N-Acetyltransferase"}, {"QualifierName": ["complications", "drug therapy"], "DescriptorName": "HIV Infections"}, {"QualifierName": ["epidemiology"], "DescriptorName": "Cameroon"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["therapeutic use", "adverse effects"], "DescriptorName": "Antitubercular Agents"}, {"QualifierName": ["complications", "genetics", "drug therapy"], "DescriptorName": "Tuberculosis"}, {"QualifierName": [], "DescriptorName": "Coinfection"}, {"QualifierName": ["genetics"], "DescriptorName": "Chemical and Drug Induced Liver Injury"}, {"QualifierName": [], "DescriptorName": "Acetylation"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Polymorphism, Single Nucleotide"}, {"QualifierName": [], "DescriptorName": "Young Adult"}, {"QualifierName": [], "DescriptorName": "Pharmacogenomic Variants"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "WHO. Tb-hiv factsheet 2018. 2018."}, {"Citation": "Rajman I, Knapp L, Morgan T, Masimirembwa C. African genetic diversity: implications for cytochrome P450-mediated drug metabolism and Drug Development. EBioMedicine. 2017;17:67\u201374. 10.1016/j.ebiom.2017.02.017", "ArticleIdList": ["10.1016/j.ebiom.2017.02.017", "PMC5360579", "28237373"]}, {"Citation": "Ross S, Anand SS, Joseph P, Pare G. Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues. JRSM Cardiovasc Dis 2012, 1(1).", "ArticleIdList": ["PMC3738322", "24175062"]}, {"Citation": "Wilson JF, Weale ME, Smith AC, Gratrix F, Fletcher B, Thomas MG, Bradman N, Goldstein DB. Population genetic structure of variable drug response. Nat Genet. 2001;29(3):265\u20139. 10.1038/ng761", "ArticleIdList": ["10.1038/ng761", "11685208"]}, {"Citation": "Li J, Zhang L, Zhou H, Stoneking M, Tang K. Global patterns of genetic diversity and signals of natural selection for human ADME genes. Hum Mol Genet. 2011;20(3):528\u201340. 10.1093/hmg/ddq498", "ArticleIdList": ["10.1093/hmg/ddq498", "21081654"]}, {"Citation": "WHO: Global tuberculosis report 2019. Geneva: World Health Organization. 2019. Licence: CC BY-NC-SA 3.0 IGO. 2019."}, {"Citation": "Agbor AA, Bigna JJ, Billong SC, Tejiokem MC, Ekali GL, Plottel CS, Noubiap JJ, Abessolo H, Toby R, Koulla-Shiro S. Factors associated with death during tuberculosis treatment of patients co-infected with HIV at the Yaounde Central Hospital, Cameroon: an 8-year hospital-based retrospective cohort study (2006\u20132013). PLoS ONE. 2014;9(12):e115211. 10.1371/journal.pone.0115211", "ArticleIdList": ["10.1371/journal.pone.0115211", "PMC4266669", "25506830"]}, {"Citation": "Enoh JE, Cho FN, Manfo FP, Ako SE, Akum EA. Abnormal Levels of Liver Enzymes and Hepatotoxicity in HIV-Positive, TB, and HIV/TB-Coinfected Patients on Treatment in Fako Division, Southwest Region of Cameroon. Biomed Res Int 2020, 2020:9631731.", "ArticleIdList": ["PMC7243024", "32462039"]}, {"Citation": "Yimer G, Gry M, Amogne W, Makonnen E, Habtewold A, Petros Z, Aderaye G, Schuppe-Koistinen I, Lindquist L, Aklillu E. Evaluation of patterns of liver toxicity in patients on antiretroviral and anti-tuberculosis drugs: a prospective four arm observational study in Ethiopian patients. PLoS ONE. 2014;9(4):e94271. 10.1371/journal.pone.0094271", "ArticleIdList": ["10.1371/journal.pone.0094271", "PMC3979833", "24714066"]}, {"Citation": "Aithal GP, Watkins PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, et al. Case definition and phenotype standardization in drug-induced liver injury. Clin Pharmacol Ther. 2011;89(6):806\u201315. 10.1038/clpt.2011.58", "ArticleIdList": ["10.1038/clpt.2011.58", "21544079"]}, {"Citation": "Genomes Project C, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68\u201374. 10.1038/nature15393", "ArticleIdList": ["10.1038/nature15393", "PMC4750478", "26432245"]}, {"Citation": "Pallerla SR, Assiana DOE, Linh LTK, Cho FN, Meyer CG, Fagbemi KA, Adegnika AA, Penlap VB, Achidi EA, Kahunu GM et al. Pharmacogenetic considerations in the treatment of co-infections with HIV/AIDS, Tuberculosis and malaria in Congolese populations of Central Africa. Int J Infect Dis 2020.", "ArticleIdList": ["33310105"]}, {"Citation": "Yimer G, Ueda N, Habtewold A, Amogne W, Suda A, Riedel KD, Burhenne J, Aderaye G, Lindquist L, Makonnen E, et al. Pharmacogenetic & pharmacokinetic biomarker for efavirenz based ARV and rifampicin based anti-TB drug induced liver injury in TB-HIV infected patients. PLoS ONE. 2011;6(12):e27810. 10.1371/journal.pone.0027810", "ArticleIdList": ["10.1371/journal.pone.0027810", "PMC3232196", "22162992"]}, {"Citation": "Assob JCN, NDE PF, NJUNDA NSAGHADS, NGUM AL, N. M., NGOWE NM. Incidence and risk factors of anti-tuberculosis drugs Induced Hepatotoxicity in HIV/AIDS patients attending the Limbe and Buea Regional hospitals. J AIDS Clin Res 2014."}, {"Citation": "Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R. Antituberculosis drug-induced hepatotoxicity: concise up-to-date review. J Gastroenterol Hepatol. 2008;23(2):192\u2013202. 10.1111/j.1440-1746.2007.05207.x", "ArticleIdList": ["10.1111/j.1440-1746.2007.05207.x", "17995946"]}, {"Citation": "Jones M, Nunez M. Liver toxicity of antiretroviral drugs. Semin Liver Dis. 2012;32(2):167\u201376. 10.1055/s-0032-1316472", "ArticleIdList": ["10.1055/s-0032-1316472", "22760656"]}, {"Citation": "Hassen Ali A, Belachew T, Yami A, Ayen WY. Anti-tuberculosis drug induced hepatotoxicity among TB/HIV co-infected patients at Jimma University Hospital, Ethiopia: nested case-control study. PLoS ONE. 2013;8(5):e64622. 10.1371/journal.pone.0064622", "ArticleIdList": ["10.1371/journal.pone.0064622", "PMC3655990", "23696901"]}, {"Citation": "Huang YS, Chern HD, Su WJ, Wu JC, Lai SL, Yang SY, Chang FY, Lee SD. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology. 2002;35(4):883\u20139. 10.1053/jhep.2002.32102", "ArticleIdList": ["10.1053/jhep.2002.32102", "11915035"]}, {"Citation": "Mitchell JR, Zimmerman HJ, Ishak KG, Thorgeirsson UP, Timbrell JA, Snodgrass WR, Nelson SD. Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med. 1976;84(2):181\u201392. 10.7326/0003-4819-84-2-181", "ArticleIdList": ["10.7326/0003-4819-84-2-181", "766682"]}, {"Citation": "Singla N, Gupta D, Birbian N, Singh J. Association of NAT2, GST and CYP2E1 polymorphisms and anti-tuberculosis drug-induced hepatotoxicity. Tuberculosis (Edinb). 2014;94(3):293\u20138. 10.1016/j.tube.2014.02.003", "ArticleIdList": ["10.1016/j.tube.2014.02.003", "24637014"]}, {"Citation": "Chan SL, Chua APG, Aminkeng F, Chee CBE, Jin S, Loh M, Gan SH, Wang YT, Brunham LR. Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients. PLoS ONE. 2017;12(10):e0186200. 10.1371/journal.pone.0186200", "ArticleIdList": ["10.1371/journal.pone.0186200", "PMC5642896", "29036176"]}, {"Citation": "Sileshi T, Telele NF, Burkley V, Makonnen E, Aklillu E. Correlation of N-acetyltransferase 2 genotype and acetylation status with plasma isoniazid concentration and its metabolic ratio in Ethiopian tuberculosis patients. Sci Rep. 2023;13(1):11438. 10.1038/s41598-023-38716-3", "ArticleIdList": ["10.1038/s41598-023-38716-3", "PMC10349800", "37454203"]}, {"Citation": "Yang S, Hwang SJ, Park JY, Chung EK, Lee JI. Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis. BMJ Open. 2019;9(8):e027940. 10.1136/bmjopen-2018-027940", "ArticleIdList": ["10.1136/bmjopen-2018-027940", "PMC6688699", "31375612"]}, {"Citation": "Khan S, Mandal RK, Elasbali AM, Dar SA, Jawed A, Wahid M, Mahto H, Lohani M, Mishra BN, Akhter N et al. Pharmacogenetic association between NAT2 gene polymorphisms and isoniazid induced hepatotoxicity: trial sequence meta-analysis as evidence. Biosci Rep 2019, 39(1).", "ArticleIdList": ["PMC6331676", "30509962"]}, {"Citation": "Hayden MS, Ghosh S. NF-kappaB in immunobiology. Cell Res. 2011;21(2):223\u201344. 10.1038/cr.2011.13", "ArticleIdList": ["10.1038/cr.2011.13", "PMC3193440", "21243012"]}, {"Citation": "Zhang J, Zhao Z, Bai H, Wang M, Jiao L, Peng W, Wu T, Liu T, Chen H, Song X, et al. Genetic polymorphisms in PXR and NF-kappaB1 influence susceptibility to anti-tuberculosis drug-induced liver injury. PLoS ONE. 2019;14(9):e0222033. 10.1371/journal.pone.0222033", "ArticleIdList": ["10.1371/journal.pone.0222033", "PMC6730870", "31490979"]}, {"Citation": "Marelize S, Michelle S, Ambroise W, Luke K, Nyasha Co, Collet D. CYP1A2, CYP2A6, CYP2B6, CYP3A4 and CYP3A5 polymorphisms in two Bantu-speaking populations from Cameroon and South Africa: implications for global pharmacogenetics. Curr Pharmacogenom Personal Med. 2012;10(1):43\u201353.10.2174/1875692111201010043", "ArticleIdList": ["10.2174/1875692111201010043"]}, {"Citation": "Paganotti GM, Russo G, Sobze MS, Mayaka GB, Muthoga CW, Tawe L, Martinelli A, Romano R, Vullo V. CYP2B6 poor metaboliser alleles involved in efavirenz and nevirapine metabolism: CYP2B6*9 and CYP2B6*18 distribution in HIV-exposed subjects from Dschang, Western Cameroon. Infect Genet Evol. 2015;35:122\u20136. 10.1016/j.meegid.2015.08.003", "ArticleIdList": ["10.1016/j.meegid.2015.08.003", "26247717"]}, {"Citation": "Nguefeu Nkenfou C, Atogho Tiedeu B, Nguefeu Nkenfou C, Nji AM, Chedjou JP, Tah Fomboh C, Kouanfack C, Mbacham WF. Adverse drug reactions Associated with CYP 2B6 polymorphisms in HIV/AIDS-Treated patients in Yaounde, Cameroon. Appl Clin Genet. 2019;12:261\u20138. 10.2147/TACG.S226318", "ArticleIdList": ["10.2147/TACG.S226318", "PMC6941599", "31920362"]}, {"Citation": "Sinxadi PZ, Leger PD, McIlleron HM, Smith PJ, Dave JA, Levitt NS, Maartens G, Haas DW. Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa. Br J Clin Pharmacol. 2015;80(1):146\u201356. 10.1111/bcp.12590", "ArticleIdList": ["10.1111/bcp.12590", "PMC4500334", "25611810"]}, {"Citation": "Mutagonda RF, Kamuhabwa AAR, Minzi OMS, Massawe SN, Asghar M, Homann MV, Farnert A, Aklillu E. Effect of pharmacogenetics on plasma lumefantrine pharmacokinetics and malaria treatment outcome in pregnant women. Malar J. 2017;16(1):267. 10.1186/s12936-017-1914-9", "ArticleIdList": ["10.1186/s12936-017-1914-9", "PMC5496343", "28673292"]}]}], "History": [{"Year": "2024", "Month": "3", "Day": "19"}, {"Year": "2024", "Month": "7", "Day": "22"}, {"Year": "2024", "Month": "8", "Day": "1", "Hour": "6", "Minute": "41"}, {"Year": "2024", "Month": "8", "Day": "1", "Hour": "0", "Minute": "41"}, {"Year": "2024", "Month": "7", "Day": "31", "Hour": "23", "Minute": "45"}, {"Year": "2024", "Month": "7", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["39085767", "PMC11293078", "10.1186/s12879-024-09638-w", "10.1186/s12879-024-09638-w"]}}]}